Chairman of the Board
Education: MA in humanities from the University of Copenhagen.
Background: Worked for more than 20 years at the international management consulting firm McKinsey & Company, specializing in healthcare, biotech, pharmaceuticals and life sciences, since 2007 as a Partner and since 2013 as a Senior Partner, until 2021. In that role, he has advised companies globally on strategy, growth and transformations, including drug development and innovation.
Other ongoing assignments: Chairman Re-Zip ApS, Board member in Immunovia AB and Rehaler A/S.
Independence: Independent in relation to both the Company and executive management.
Scandion Oncology shares and warrants
64,746 shares, 43,860 TO2 warrants, 14,620 TO3 warrants and 128,542 Incentive warrants.